The mutual effects on safety and immunogenicity of combined vaccination with 15-valent pneumococcal conjugate vaccine and adsorbed acellular DPT in 3-month heal

To evaluate the mutual effects on safety and immunogenicity of the combined vaccination of the 15-valent pneumococcal conjugate vaccine (PCV15) and the adsorbed acellular diphtheria-tetanus-pertussis combined vaccine (DTaP) in healthy infants aged 3 months (90 to 119 d) old. This

Medical Literature · Updated 2026-08-07

← Back to articles

This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.